Barium(II)–2,4‐dinitrophenolate–18‐crown‐6 at 183 K

The title compound, bis(2,4‐dinitrophenolato‐κ²O,O′)(1,4,7,10,13,16‐hexaoxadecane‐κ⁶O)barium(II), [Ba(C₆H₃N₂O₅)₂(C₁₂H₂₄O₆)], is a 1:1 complex of barium(II)–2,4‐di­nitro­phenolate and 1,4,7,10,13,16‐hexaoxa­cyclo­octa­decane (18‐crown‐6). Its structure is located on a crystallographic inversion centre. The temperature dependence of the crystal structure has been studied. The monoclinic β angle of the P2₁/­n space group increases with increasing temperature. The packing structure of the complex is stabilized by intermolecular C—H?O interactions.     

1‐Acetyl‐3′‐(4‐bromophenyl)‐3′‐chlorospiro[3H‐indole‐3,2′‐oxetan]‐2(1H)‐one

In the title compound, C₁₈H₁₃BrClNO₃, the heterocyclic ring of the indole is distorted from planarity towards an envelope conformation. The orientations of the indole, oxetane, chloro and bromo­phenyl substituents are conditioned by the sp³ states of the spiro‐junction and the Cl‐attached C atoms.     

Di‐2‐pyridyl ketone N4,N4‐(butane‐1,4‐diyl)thiosemicarbazone

The title compound, C₁₆H₁₇N₅S, is in the thione form and crystallizes with two independent mol­ecules in the asymmetric unit. In both mol­ecules, the penta­methyl­ene­imine five‐membered ring adopts an envelope conformation, and in one of the molecules this ring shows positional disorder. The thione S and hydrazine N atoms are in the Z configuration with respect to the C—N bond.     

2‐Hydro­xy‐3‐(4,5,6,7‐tetra­hydro‐1H‐imidazo­[4,5‐c]­pyridin‐5‐ium‐4‐yl)­benzoate monohydrate

The title mol­ecule, C₁₃H₁₃N₃O₃·H₂O, is in the form of a mono­hydrated zwitterion. The tetra­hydro­pyridinium ring adopts an envelope conformation and is nearly coplanar with the plane of the imidazoline ring. The water solvate mol­ecule plays an important role as a bridge between zwitterions, forming molecular chains running along the c direction, which are interconnected by N—H?O hydrogen bonds into molecular ribbons. The crystal packing is further stabilized by another N—H?O and one O—H?N hydrogen bond, which interconnect the molecular ribbons.     

Extraction and coordination studies of carbamoyl methyl sulfoxide (CMSO) with uranyl bis(β-diketonates). Synthesis and molecular structure of [{UO2(DBM)2}2C6H5CH2SOCH2CONHC6H5]

The carbamoyl methyl sulfoxide compounds of uranyl bis(β-diketonate) of the types [UO₂(DBM)₂CMSO] and [{UO₂(DBM)₂}₂CMSO] (where HDBM = C₆H₅COCH₂COC₆H₅; CMSO = C₆H₅CH₂SOCH₂CONHC₆H₅ or C₆H₅SOCH₂CONⁱPr₂) have been synthesized and characterized by IR and NMR spectroscopic techniques and elemental analysis. Spectral studies show that CMSO acts as a monodentate ligand in [UO₂(DBM)₂CMSO] compounds and bonds through the sulfoxo oxygen atom to the uranyl group. It acts as a bridging bidentate ligand in [{UO₂(DBM)₂}₂CMSO] compounds and bonds through both the sulfoxo and carbamoyl oxygen atoms to two different uranyl groups. The structure of the compound [{UO₂(DBM)₂}₂C₆H₅CH₂SOCH₂CONHC₆H₅] confirms the bridging bidentate mode of coordination for the CMSO ligand. Extraction studies show an enhancement in solvent extraction for the uranyl ion from nitric acid medium when a mixture of thenoyl trifluoroacetone (HTTA) and CMSO was employed.     

Evaluation of Phytochemistry and Pharmacological Properties of Alnus nitida

In the current study, the anti-inflammatory and analgesic potential of Alnus nitida (leaves and fruits) was evaluated in the Sprague-Dawley rat. Traditionally, A. nitida was used for the treatment of inflammatory ailments. However, A. nitida leaves and fruits have not been yet reported regarding any potential medicinal effects. Leaves/fruits of A. nitida were extracted with methanol and fractionated to attain n-hexane, chloroform, ethyl acetate and aqueous fractions. These extracts were then evaluated for in vivo analgesic and anti-inflammatory potential. For in vivo anti-inflammatory activity, carrageenan-induced paw edema assay, Freunds’ complete adjuvant-induced edema, xylene-induced ear edema and histamine-induced paw edema models were used in rats, which showed significant (p < 0.01) reduction (70–80%) in edema in comparison of inflammatory controls. On other hand, for the analgesic assessment, hot plate assay and acetic acid-induced writhing tests were used, which showed a significant (p < 0.01) rise in latency time (40–60%) as compared with pain-induced controls. These results were comparable with standard drugs in a concentration-dependent manner and no mortality or toxicity was observed during all experiments. Then, for the identification of chemical constituents gas chromatography–mass spectrometry (GC-MS) analysis was performed, which indicated the presence of neophytadiene, 3,7,11,15-Tetramethyl-2-hexadecen-1-ol, phytol and vitamin E, justifying the use of A. nitida to treat inflammatory disorders.     

Efficient barrier properties of mechanically enhanced agro-extracted cellulosic biocomposites

The objective of this work was to prepare the mechanically stable hydrophobic biocomposites by incorporating the cellulose fibers into the polymer matrices for their applications in biomedical and food packaging. Herein, two different types of biocomposites were prepared by mixing polylactic acid (PLA) and polyhydroxybutyrate (PHB) with the agro-extracted cellulose, separately at 170 °C. The influence of the cellulose fibers on the thermal, mechanical, and barrier properties of polymer matrices (PLA and PHB) was observed. With an increase in the cellulose content in PLA and PHB, the tensile strength of the biocomposite materials significantly improved with the enhancement of 24.45% and 32.08%, respectively, compared with the pure PLA and PHB. Furthermore, a decrease of 74.16% and 73.49% in the water vapor transmission rate and oxygen transmission rate, respectively, was observed for cellulose/PHB biocomposites. This study highlights that adding cellulose fibers significantly improves the mechanical and the barrier properties of PLA and PHB, suggesting their biocomposites for use in biodegradable polymer industries.     

Nephroprotective Effects of Alhagi camelorum against Cisplatin-Induced Nephrotoxicity in Albino Wistar Rats

Alhagi camelorum (AC) is an old plant with a significant therapeutic value throughout Africa, Asia, and Latin America. The overuse of cisplatin (Cis > 50 mg/m²) is associated with observed nephrotoxicity, ototoxicity, gastrotoxicity, myelosuppression, and allergic reactions. Remedial measures are needed for the protection of nephrotoxicity against cisplatin. Thus, we investigated the nephroprotective effects of AC plant extract to prevent cisplatin-induced nephrotoxicity in albino Wistar rats. The presence of polyphenols, phenolic compounds, tannins, and saponins was revealed during phytochemical investigation, and a significantly intense antioxidant activity was recorded. There were no toxicological symptoms in the treated rats, and no anatomical, physiological, or histological abnormalities were found compared to the control rats. The results of correcting cisplatin-induced nephrotoxicity revealed that the extract has a significant ability to treat kidney damage, with most parameters returning to normal after only three weeks of therapy. It is concluded that co-administration of cisplatin with AC extract showed exceptional nephroprotective effects at a dose of 600 mg/kg for Cis-induced nephrotoxicity.